Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars From Prior Breast Surgery

ClinicalTrials.gov ID: NCT01346969

Public ClinicalTrials.gov record NCT01346969. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 10:25 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 2, RANDOMIZED, DOUBLE-BLIND, WITHIN-SUBJECT CONTROLLED STUDY TO EVALUATE EFFICACY AND SAFETY OF VARIOUS DOSES AND REGIMENS OF EXC 001 FOR THE AMELIORATION OF SCARRING FOLLOWING REVISION OF SCARS FROM PRIOR BREAST SURGERY IN ADULT SUBJECTS (LEGACY EXCALIARD PROTOCOL # EXC 001-204)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study will investigate the efficacy of various doses and regimens of EXC 001 in reducing skin scarring in subjects undergoing revision of scars from prior surgery. The study will also evaluate the safety and tolerability of EXC 001 and placebo.

Study identification

NCT ID
NCT01346969
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
68 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 1, 2011 (Actual)
Primary completion
Apr 16, 2012 (Actual)
Completion
Apr 16, 2012 (Actual)
Last update posted
Sep 9, 2021

2011 – 2012

United States locations

U.S. sites
12
U.S. states
7
U.S. cities
10
Facility City State ZIP Site status
Skin Deep Laser Medical Spa Pasadena California 91105 —
Bright Health Physicans Plastic Surgery and Aesthetic Medicine Whittier California 90602 —
Altus Research Lake Worth Florida 33461 —
Bayside Ambulatory Center Miami Florida 33133 —
Aesthetic Plastic Surgery Miami Miami Florida 33146 —
Body Aesthetic Plastic Surgery St Louis Missouri 63141 —
New Jersey Plastic Surgery Montclair New Jersey 07042 —
Mark L. Jewell,MD Surgery Center Eugene Oregon 97401 —
Connall Consmetic Surgery Tualatin Oregon 97062 —
Endeavor Clinical Trials,P.A. San Antonio Texas 78229 —
Texas Plastic Surgery San Antonio Texas 78240-1670 —
BAXTER Plastic Surgery Mountlake Terrace Washington 98043 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01346969, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 9, 2021 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01346969 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →